Enclomiphene vs TRT: what bloodwork actually tells you

What did @davidj.rau actually say?

This is a guy showing his bloodwork after 10 weeks on 150mg testosterone cypionate, self-described as a "cruise" dose between heavier steroid cycles. He walked through his labs panel by panel, flagging suppressed LH and FSH as expected, low HDL as a steroid side effect, elevated free testosterone, slightly low estradiol, and a mildly elevated RDW he attributed to hard training. His closing line, "time to blast," signals he's moving from a maintenance dose to a higher-dose cycle. He's not pretending this is standard TRT for hypogonadism. He's describing performance-enhancing drug use with some health monitoring layered on top.

That transparency is actually somewhat rare in this corner of TikTok, and it matters for how we evaluate the rest of what he said.

Does the science back this up?

Mostly, yes, on the physiology. The suppression of LH and FSH on exogenous testosterone is about as well-established as anything in endocrinology. Testosterone administered from outside the body signals the hypothalamic-pituitary-gonadal axis to shut down endogenous production. Bhasin et al. (2001, New England Journal of Medicine) documented this dose-dependent suppression clearly. His description of LH and FSH being "in the ground" after a year of cruising is accurate and expected.

His HDL comment also checks out. Bagatell and Bremner (1996, Annals of Internal Medicine) showed that supraphysiologic androgen use consistently lowers HDL cholesterol, sometimes dramatically. The RDW-exercise connection is supported too. Lippi et al. (2014, Clinical Chemistry and Laboratory Medicine) found strenuous endurance and resistance training can increase RDW, though the mechanism isn't fully pinned down yet.

Where things get murkier is the estradiol interpretation and the framing around free testosterone.

What did they get wrong (or right)?

Let's give credit first. He correctly identified that low estradiol is a problem, not a goal. A lot of guys in the steroid community over-suppress estrogen chasing "dry" physiques and end up with joint pain, low libido, and cardiovascular risk. His instinct to raise testosterone to bring estradiol up rather than reach for an aromatase inhibitor is actually more aligned with current clinical thinking than most of what you see on TRT TikTok.

The "free testosterone through the roof" framing deserves scrutiny though. He presents high free testosterone as straightforwardly good. It isn't that simple. Free testosterone drives both anabolic effects and androgenic side effects, including erythrocytosis, prostate stimulation, and cardiovascular strain. Traish et al. (2015, Journal of Sexual Medicine) noted that the relationship between free testosterone levels and outcomes is not linear. More is not always better, and presenting it as unambiguously positive is an oversimplification that could mislead someone newer to this.

He also casually calls LH and FSH suppression "birth control," which is technically accurate for fertility purposes but glosses over the fact that prolonged suppression can affect testicular recovery, a real concern documented in Coviello et al. (2004, Journal of Clinical Endocrinology and Metabolism).

What should you actually know?

If you're using testosterone at any dose, a few things matter that this video doesn't cover adequately. First, HDL suppression from androgen use is not a minor inconvenience. Zmuda et al. (1993, Metabolism) linked androgenic steroid use to atherogenic lipid profiles with real cardiovascular consequences. He promises a follow-up video on fixing it, which is fine, but anyone watching should understand that "a little low" HDL in the context of year-long steroid use is a meaningful risk signal, not a footnote.

Second, the prostate panel showing healthy results at his current age and dose doesn't mean prostate health is permanently settled. Testosterone use accelerates prostate-specific antigen (PSA) changes in some men, and longer follow-up matters. Morgentaler and Traish (2009, European Urology) challenged the old fear that testosterone causes prostate cancer, but they also didn't give blanket clearance for supraphysiologic use over years.

Third, and most importantly for anyone who isn't a long-term steroid user: what he describes is not standard TRT. Supervised TRT for hypogonadism typically targets mid-normal physiologic testosterone ranges under physician monitoring. What he describes, cruising at 150mg as a base between blast cycles, is a performance-enhancement protocol. Those are different things with different risk profiles, and conflating them based on this video would be a mistake.

The bottom line on this video

He's more honest than most. He labels what he's doing, he's getting regular bloodwork, and he flags the actual problems in his panel rather than hiding them. The science behind his LH and FSH suppression claims, his HDL commentary, and his estradiol reasoning is largely sound. But presenting sky-high free testosterone as simply "lit" and breezing past a year of HPG axis suppression as no big deal are real gaps. This is a useful window into how an experienced steroid user monitors himself. It's not a template for anyone else to follow.